Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination: application to node-negative breast cancer.

Onody P, Bertrand F, Muzeau F, Bièche I, Lidereau R.

Arch Pathol Lab Med. 2001 Jun;125(6):746-50.

PMID:
11371225
2.

Breast cancer in the 21st century: neu opportunities and neu challenges.

Schnitt SJ.

Mod Pathol. 2001 Mar;14(3):213-8. Review.

3.
4.

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

Ross JS, Fletcher JA.

Am J Clin Pathol. 1999 Jul;112(1 Suppl 1):S53-67. Review.

PMID:
10396301
5.

Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing.

Cell Markers And Cytogenetics Committees College Of American Pathologists.

Arch Pathol Lab Med. 2002 Jul;126(7):803-8. Review.

PMID:
12088449
6.

[HER-2 diagnostics].

Bánkfalvi A.

Magy Onkol. 2002;46(1):11-5. Epub 2003 Feb 3. Review. Hungarian.

7.

Her-2/neu and breast cancer.

Kaptain S, Tan LK, Chen B.

Diagn Mol Pathol. 2001 Sep;10(3):139-52. Review.

PMID:
11552716
8.

HER-2/neu testing in breast cancer.

Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Hortobagyi GN.

Am J Clin Pathol. 2003 Dec;120 Suppl:S53-71. Review.

PMID:
15298144
9.

[HER-2/neu-testing in breast cancer: is the immunocytochemistry competent?].

Matsionis AÉ, Pavlenko IA, Petrov AV, Povilaĭtite PE.

Arkh Patol. 2012 Mar-Apr;74(2):42-5. Review. Russian.

PMID:
22880415
10.

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.

Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ.

Oncologist. 2003;8(4):307-25. Review.

11.

Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH - case report and review of the literature.

Kucukzeybek BB, Yigit S, Sari AA, Rezanko T, Durak E, Sadullahoglu C.

Pol J Pathol. 2014 Mar;65(1):70-3. Review.

12.

High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients.

Jiang W, Jin Z, Zhou F, Cui J, Wang L, Wang L.

Surg Oncol. 2015 Sep;24(3):220-5. doi: 10.1016/j.suronc.2015.05.004. Epub 2015 Jun 3. Review.

PMID:
26096373
13.

[Recent trends in pathological diagnosis of breast cancer].

Kurosumi M.

Nihon Rinsho. 2006 Mar;64(3):451-60. Review. Japanese.

PMID:
16529035
14.

[New trends in diagnostics and classification of breast carcinoma].

Ryska A, Laco J, Hornychová H, Hornychová E, Melichar B.

Cesk Patol. 2009 Apr;45(2):29-34. Review. Czech.

PMID:
19534390

Supplemental Content

Support Center